Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Patient preferences and National Health Service costs: a cost-consequences analysis of cancer genetic services

Griffith, Gethin L., Tudor Edwards, Rhiannon, Williams, J. Mark G., Gray, Jonathon, Morrison, Val, Wilkinson, Clare Elizabeth, Turner, Jim, France, Barbara Diane and Bennett, Paul David 2009. Patient preferences and National Health Service costs: a cost-consequences analysis of cancer genetic services. Familial Cancer 8 (4) , pp. 265-275. 10.1007/s10689-008-9217-5

Full text not available from this repository.


The study has three aims; firstly to establish if, having been informed of their risk status and that gene testing is inappropriate for them, low and moderate risk patients have misunderstood or failed to grasp this and want a test that is inappropriate for them. Secondly, to elicit patients’ willingness to pay for cancer genetic services. Thirdly, to ascertain the aspects of cancer genetics services that are important to high risk patients and present service configurations prioritised in terms of preferences accompanied by their costs (cost-consequences analysis). Patient preferences were gathered from 120 patients returning a self-administered discrete choice questionnaire issued post genetic risk assessment. Patients at low and moderate risk of developing breast cancer desired inappropriate testing. Patients at high, moderate and low risk of developing genetic cancer were willing to pay up to £3,000 for genetic serviced, which exceeds the current estimated cost of providing testing and counselling. Counselling by a genetics associate accompanied by favourable levels of other attributes provided high utility and substantial cost savings.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Subjects: Q Science > QH Natural history > QH426 Genetics
R Medicine > R Medicine (General)
R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Uncontrolled Keywords: Genetic; Breast cancer; Discrete choice experiment/modelling; Cost-consequences
Publisher: Springer
ISSN: 1389-9600
Last Modified: 10 Oct 2017 14:03

Citation Data

Cited 8 times in Google Scholar. View in Google Scholar

Cited 7 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item